- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/46 - Pills, lozenges or tablets effervescent
Patent holdings for IPC class A61K 9/46
Total number of patents in this class: 360
10-year publication summary
|
40
|
41
|
33
|
41
|
20
|
33
|
22
|
18
|
19
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dr. Falk Pharma GmbH | 186 |
10 |
| Amerilab Technologies, Inc. | 21 |
9 |
| The Procter & Gamble Company | 21893 |
8 |
| Sanovel Ilac Sanayi ve Ticaret A.S. | 295 |
8 |
| SpecGx LLC | 186 |
8 |
| Galderma Research & Development | 371 |
6 |
| Steerlife India Private Limited | 24 |
6 |
| Symrise AG | 1812 |
6 |
| Bayer HealthCare LLC | 1304 |
5 |
| Cephalon, Inc. | 111 |
5 |
| Georgia Tech Research Corporation | 2901 |
4 |
| ABIC Biological Laboratories Ltd. | 8 |
4 |
| Tower Laboratories, Ltd. | 20 |
4 |
| Nicoventures Trading Limited | 4492 |
4 |
| Amneal Complex Products Research LLC | 64 |
4 |
| The Regents of the University of California | 20556 |
3 |
| AstraZeneca AB | 2837 |
3 |
| The General Hospital Corporation | 4824 |
3 |
| Alpex Pharma S.A. | 21 |
3 |
| Assistance Publique - Hopitaux de Paris | 1031 |
3 |
| Other owners | 254 |